Plant Advanced Technologies SA (EPA:ALPAT)
France · Delayed Price · Currency is EUR 8.34
0.00 (0.00%)
At close: Feb 20, 2026
EPA:ALPAT Market Cap
EPA:ALPAT has a market cap or net worth of €9.36 million as of February 20, 2026. Its market cap has decreased by -26.56% in one year.
Market Cap
9.36M
Enterprise Value
13.34M
Revenue
2.22M
Ranking
n/a
PE Ratio
9.93
Stock Price
€8.34
Market Cap Chart
Since August 5, 2009, EPA:ALPAT's market cap has increased from 6.22M to 9.36M, an increase of 50.41%. That is a compound annual growth rate of 2.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 9.36M | 1.71% |
| Dec 31, 2025 | 9.20M | -30.22% |
| Dec 31, 2024 | 13.18M | 43.55% |
| Dec 29, 2023 | 9.18M | -36.37% |
| Dec 30, 2022 | 14.43M | -28.63% |
| Dec 31, 2021 | 20.23M | -10.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 36.57M |
| Advicenne | 30.11M |
| genOway Société anonyme | 22.77M |
| Aelis Farma | 18.76M |
| GenSight Biologics | 17.95M |
| Poxel | 14.78M |
| NFL Biosciences | 14.07M |
| Oncodesign Precision Medicine Société anonyme | 9.04M |